Loading…
Loading… fetching the latest figures.
Loading…
Loading… fetching the latest figures.
GH
Guardant Health, Inc. is a Health Care company listed on NASDAQ NMS - GLOBAL MARKET.
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
via Wikipedia →The basics, explained simply — no finance degree required.
The lowest and highest price this stock has traded at over the past year.
How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.
How much the company's sales grew compared to a year ago.
How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.
Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.
| Fiscal year ending | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| RevenueGrowth = this year ÷ prior year − 1 | $982M+32.9% | $739M+31.0% | $564M | — |
| Operating incomeMargin = operating income ÷ revenue | -$437M-44.5% margin | -$444M-60.0% margin | -$565M-100.1% margin | -$544M |
| Net incomeMargin = net income ÷ revenue | -$416M-42.4% margin | -$436M-59.0% margin | -$479M-85.0% margin | -$655M |
| Operating cash flowCash the business generated, vs net income above | -$185M | -$240M | -$325M | -$309M |
| Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases | — | -$617M$526M cash · $1.1B debt | — | — |
| Shares (weighted avg.)Change = this year ÷ prior year − 1 | 125M+2.1% | 123M+9.6% | 112M+9.6% | 102M+0.9% |
Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.
Weighted average shares rose 22.7% between Dec 2022 and Dec 2025 (2.1% in the latest year).
| Shares (weighted avg.) | Dec 2025 | 125M |
| Shares (weighted avg.) | Dec 2024 | 123M |
| Shares (weighted avg.) | Dec 2022 | 102M |
How it's calculated: Share growth = weighted average shares ÷ earlier-year weighted average shares − 1.
Rule: Weighted average shares up 5% or more in a year, or 10% or more over three years.
Why it can matter: When a company issues new shares, each existing share becomes a smaller slice of the profits, so earnings per share can lag total earnings.
Common innocent explanations: Shares issued to pay for an acquisition or to fund growth, or employee share awards that vest over time.
See every flagged company in Market Watch →
Source: SEC EDGAR annual reports (Form 10-K), latest filed 2026-02-19. If a company later restates a year, the most recent filing is used. Dashes mean the company did not report that line in a form we could read. For information only, not investment advice.